0001213900-20-040052.txt : 20201230 0001213900-20-040052.hdr.sgml : 20201230 20201130175304 ACCESSION NUMBER: 0001213900-20-040052 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20201130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medigus Ltd. CENTRAL INDEX KEY: 0001618500 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: BUILDING 7A, OMER INDUSTRIAL PARK STREET 2: POB 3030 CITY: OMER STATE: L3 ZIP: 8496500 BUSINESS PHONE: 972722602211 MAIL ADDRESS: STREET 1: BUILDING 7A, OMER INDUSTRIAL PARK STREET 2: POB 3030 CITY: OMER STATE: L3 ZIP: 8496500 CORRESP 1 filename1.htm

November 30, 2020

VIA EDGAR

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Re:

Medigus Ltd.

Registration Statement on Form F-1, as amended (File No. 333-249797)

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as the underwriter of the proposed offering of Medigus Ltd. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 4:30 p.m., Eastern Time, on Tuesday, December 1, 2020, or as soon thereafter as is practicable.

Pursuant to Rule 460 of the General Rules and Regulations under the Act, the undersigned advises that as of the date hereof, [0] copies of the Preliminary Prospectus dated November 2, 2020 have been distributed to retail investors and others.

The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities and Exchange Act of 1934, as amended.

		Very truly yours,

		Aegis Capital Corp.

		By:	/s/ Victor Halpert
			Name: Victor Halpert Title: Managing Director